Preveceutical Medical Stock Target Price
| PRVCF Stock | USD 0.02 0 35.00% |
Fundamental analysis of PreveCeutical Medical allows traders to better anticipate movements in PreveCeutical Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
PreveCeutical |
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
PreveCeutical Fundamentals
| Return On Asset | -3.31 | |||
| Current Valuation | 12.06 M | |||
| Shares Outstanding | 523.3 M | |||
| Shares Owned By Insiders | 24.08 % | |||
| Price To Sales | 3,902 X | |||
| Gross Profit | 2.25 K | |||
| EBITDA | (1.28 M) | |||
| Net Income | (1.73 M) | |||
| Cash And Equivalents | 2.64 K | |||
| Total Debt | 1.68 M | |||
| Debt To Equity | 347.60 % | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (426.39 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | 1.08 | |||
| Market Capitalization | 11.93 M | |||
| Total Asset | 161.2 K | |||
| Z Score | -18.9 | |||
| Net Asset | 161.2 K |
About PreveCeutical Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PreveCeutical Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PreveCeutical Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PreveCeutical Medical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in PreveCeutical OTC Stock
PreveCeutical Medical financial ratios help investors to determine whether PreveCeutical OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PreveCeutical with respect to the benefits of owning PreveCeutical Medical security.